Huntington Bancshares Incorporated (NASDAQ: HBAN) — The Cheaper Ohio Twin, With the Synergies Thrown In Free

Date: June 19, 2026 Price reference: $16.86 (close 2026-06-18) · Shares ≈ 2,027M (post-Cadence) · Market cap ≈ $34.2B Sector: Financials — U.S. Regional Bank Holding Company · CIK: 0000049196 · HQ: Columbus, Ohio

Standing disclaimer: This article is independent fundamental research for general information only. Sections 1–15 (the analytical body) carry no buy/sell recommendation and no price target — valuation is discussed only as embedded expectations and scenarios. The sole, deliberate exception is the clearly-labeled “Claude’s Take” block immediately below, which is the author’s own opinion and not investment advice.

⚡ Claude’s Take

This block is the author’s own subjective opinion and general information only — not investment advice. The analytical body (§1–§15) below it takes no position and contains no price target.

Verdict: BUY / accumulate at $16.86 — a better-credit, cheaper version of its own Ohio twin, with the Cadence synergies priced out. Add on weakness toward the mid-$14s; not a name to chase above the high-$18s. Directional zone: Fair value ~$17.50–$19.50 on base-case economics (≈1.85–1.95x post-Cadence tangible book, ≈11–12x normalized EPS) at the current 16–17% ROTCE. The bull zone (~$20–$21, ≈2.1–2.2x TBV) requires the 2027 ROTCE target of 18–19% and the mid-50s efficiency ratio to land; the bear zone (~$13–$14.50, ≈1.4–1.5x TBV) requires integration to leak and ROTCE to slip toward 13–14%.

Tag: “Better bank, lower price, deal still in the show-me window.”

Huntington is one of the better-underwritten super-regionals in the country, and the market is paying less for it than for its near-identical Ohio twin Fifth Third. The evidence of quality is in the numbers, not the narrative: a best-in-class 35% cumulative deposit beta, net charge-offs of just 0.23% (less than half FITB’s 0.60%), a deliberately low ~10% CRE concentration, a #1-ranked J.D. Power 2026 consumer digital experience that converts into peer-leading household growth, and a through-cycle ROA around 1.05% with ROTCE of 16–17%. Yet at ~1.78x post-Cadence tangible book and ~11x forward earnings, HBAN trades at a clear discount to FITB (~1.95–2.0x TBV), Regions (~2.0x) and U.S. Bancorp (~2.0x) — banks with comparable ROTCE and materially worse credit. A justified-multiple framework (ROTCE 16–17%, cost of equity ~10.5%, growth ~3.5%) supports ~1.85–1.90x today, so the stock is fair-to-modestly-cheap before any deal benefit. Invert it and the message is sharper: at 1.78x TBV the market is underwriting roughly today’s ~16% ROTCE with zero credit for Cadence cost synergies or the raised 18–19% 2027 target. You are being handed the integration optionality for free.

The reason it’s cheap is also the reason to keep conviction medium, not high: this is a bank that manufactured its scale with three all-stock deals in four-and-a-half years (TCF 2021, Veritex Oct-2025, the transformational $7.4B Cadence Feb-2026) into a structurally mediocre, low-organic-growth industry — the textbook Marathon asset-growth setup that historically punishes acquirers. Cadence took the company across $250B into the permanent cost step-up of Basel Category III, pushed CET1 down to a sub-peer 10.2%, was dilutive to tangible book per share, and follows a four-year buyback drought (zero repurchases 2023–25) that means management has promised capital return ($3B evergreen authorization, ~$550M for 2026) but not yet delivered it at scale. Framing: this is a quality-and-value setup, not a momentum trade — the factor tape confirms it (a dividend-yield/value-loaded, negative-momentum regional that the market re-rated but has not chased; ~11% off its post-deal high, consolidating, not a falling knife). The asymmetry favors patient buyers because the upside (synergies + operating leverage) is real and un-priced, while the downside is the ordinary integration/cycle risk of a well-capitalized, diversified, low-CRE bank — bounded, not existential.

Conviction: medium. Flips to high-conviction bullish if HBAN posts two clean post-Cadence quarters with the cost-synergy run-rate tracking, NIM holding ≥3.2%, CET1 rebuilding toward 10.5%+, and the buyback actually executing — at which point the discount to FITB looks plainly wrong and the bull zone opens. Flips bearish if integration leaks deposits/revenue in the non-overlapping Texas/Southeast markets, credit normalizes harder than the (slightly thinning) 1.83% reserve assumes, or management answers the next cyclical lull with a fourth dilutive deal instead of the promised buyback.

📈 Stock Price Action — Five-Year Event Map

Over the trailing five years HBAN round-tripped from a COVID low of ~$6.9 (mid-2020) to an all-time high of ~$18.91 (around the Cadence close, early February 2026), and now sits at $16.86 — about −11% off that high, inside a 52-week range of roughly $14.74–$18.91. The shape is a long, choppy recovery: a 2020–21 reopening surge, a 2022–23 round-trip through the rate-hike cycle and the March-2023 regional-bank crisis, and a steady 2024–26 re-rating powered by the rate-cut pivot and the Veritex/Cadence expansion. (Prices are FACT, from the AZI 5-year CSV; attributed drivers are INTERPRETATION.)

Cycle narrative. (1) The 2020–21 leg was the sector-wide reopening reflation, amplified by the TCF merger that re-scaled the franchise. (2) The stock then went sideways and de-rated through the 2022 hiking cycle on recession fear. (3) A late-2022 NIM-expansion rally was abruptly reversed by (4) the March-2023 SVB regional-bank crisis, in which HBAN — like the whole group — sold off ~32% on deposit-flight contagion, despite its insured, granular deposit base proving resilient with no run. (5) The ensuing 18-month recovery was the largest move of the period (~+90%), driven by fading crisis fear, the rate-cut pivot, and the post-election bank rally. (6) Early-2025 macro/tariff risk-off clipped the group. (7) The 2025–26 leg to the all-time high was deal-driven — Veritex and then Cadence stepped HBAN to a ~$276B-asset top-10 bank. (8) Since the Cadence close the stock has given back ~11% as the market digests the tangible-book dilution, the dip in CET1 to 10.2%, and integration “show-me” risk. (No price target, no support/resistance, no pattern-reading — this is factual price history feeding the thesis above.)

1. Executive Summary

Huntington Bancshares is the holding company for The Huntington National Bank, a Columbus, Ohio–based super-regional founded in 1866 that, following the February 1, 2026 close of its all-stock acquisition of Cadence Bank, is now a top-ten U.S. bank with roughly $276B in assets, ~$220B of deposits, and nearly 1,400 branches across 21 states. It is, on the evidence, a very good operator inside a structurally ordinary business: a deposit-funded spread lender whose above-average execution shows up in a best-in-class deposit beta, top-quartile credit, a category-leading consumer-banking brand, and a through-cycle ROTCE of 16–17% — but roughly three-quarters of revenue is net interest income earned in a market where the bank is a price-taker.

What makes Huntington better than the average regional is measurable, not narrative. Its funding base is granular and sticky — 70% insured, only 18% non-interest-bearing yet repricing with a best-in-class 35% cumulative deposit beta as rates fall, with the cost of interest-bearing deposits down to 2.41% (FY2025). Its credit is genuinely conservative: net charge-offs of 0.23% of average loans (less than half FITB’s 0.60%), an NPA ratio of 0.63%, an above-peer 1.83% reserve, and a deliberately low ~10% commercial-real-estate concentration that side-steps the office overhang plaguing the sector. And its consumer franchise — the “Fair Play” banking suite (24-Hour Grace, Asterisk-Free Checking, Standby Cash, Early Pay) — converts into the captivity metrics that matter: #1 in the J.D. Power 2026 U.S. Online Banking and Mobile App studies, #1 in small-business satisfaction, and peer-leading ~2% household growth. These are the financial fingerprints of a real, if narrow and local, moat.

The defining event of the last two years is a deliberate, all-stock M&A transformation. Huntington stacked three deals — TCF Financial (merger of equals, 2021, ~$22B), Veritex Holdings (Dallas, Oct-2025, $1.9B), and the transformational Cadence Bank (Feb-2026, ~$7.4B, adding $54B assets / $44B deposits) — plus capital-markets bolt-ons (Janney, TM Capital), to build a second core franchise in Texas and the Southeast and a genuine fee-generating capital-markets engine. The strategic logic is coherent: escape the slow-growth, mature Midwest deposit map and diversify the fee base. But the execution is unproven at this scale, the deals diluted tangible book per share, share count went from ~1.02B (2020) to ~2.03B (post-Cadence), and Cadence pushed the company across $250B into the permanent compliance/capital cost of Basel Category III.

Financial quality is high and inflecting upward. NIM troughed at 3.00% in FY2024 and recovered to 3.13% (FY2025) and 3.24% in Q1-2026 as deposit costs fell faster than asset yields; the FY2024 AOCI securities drag is reversing (TCE/TA up to 7.1% from 6.1%); and Q1-2026 — the first post-Cadence quarter — showed adjusted PPNR +36% and NIM +9bp. The one quality blemish that recurs across the analysis is the efficiency ratio of 59.9%, which lags FITB (~54%) and Regions (~57%) — the operating advantage is incomplete, and the entire Cadence cost-synergy thesis (targeting a mid-low-54% efficiency ratio and 18–19% ROTCE by 2027) is the plan to close it.

Capital allocation is well-incentivized and disciplined on credit, but the capital-return record is weak. Executive pay is tied to the right metrics — adjusted EPS, PPNR growth, operating leverage, and relative/absolute ROTCE, not asset growth — and CEO Steve Steinour (since January 2009) has a long, returns-focused tenure. But the company repurchased zero shares in 2023, 2024 and 2025, holding the dividend flat at $0.62, while serial all-stock issuance and the AOCI drag held back per-share value: diluted EPS to common is only $1.39 (2025) versus $1.45 as far back as 2022. The new $3B authorization and ~$550M 2026 buyback plan are the promised pivot — permission, not yet proof.

Valuation is fair-to-modestly-cheap, and the “rich P/E” signal is an artifact. On the correct post-Cadence book, HBAN trades at 1.15x P/B and ~1.78x tangible book — below its ~1.85–1.90x justified multiple on current ROTCE and at an apparently unearned discount to FITB/RF/USB. The 83.6th-percentile own-history P/E is a denominator artifact (a flat multiple on a temporarily deal-charged EPS); the P/S percentile (47.8th) and composite (65th) read mid-cycle. The market is pricing ~16% sustainable ROTCE with no synergy credit. Scenario fair-value zones: bear ~$13–14.50 (≈1.4–1.5x TBV), base ~$17.50–19.50 (≈1.85–1.95x), bull ~$20–21 (≈2.1–2.2x).

Bottom line: a genuinely high-quality, conservatively-underwritten regional trading at a discount to lower-quality peers, whose forward return is now dominated by a large acquisition in its execution-proof window. The analytical body below takes no position; the variant-perception and what-must-be-true sections frame the debate.

2. Business Overview

What the company does. Huntington Bancshares is the holding company for The Huntington National Bank, a multi-state diversified regional bank organized in Maryland in 1966, serving customers since 1866 and headquartered in Columbus, Ohio. (FACT — FY2025 10-K, Business section.) It earns money the way every spread lender does: (1) net interest income (NII) — the spread between yields on loans/leases and securities and the cost of deposits and borrowings; (2) noninterest (fee) income — payments and cash management, wealth and asset management, deposit/loan fees, capital markets and advisory, mortgage banking, insurance, and leasing; and (3) increasingly, scale efficiency as it digests acquisitions. In FY2025, NII (FTE) was $6,056M (~74% of $8,231M total FTE revenue) and noninterest income $2,175M (~26%). (FACT — FY2025 10-K MD&A.) The fee share is solid for a regional but somewhat below the most fee-diversified super-regionals (FITB ~34%) — Huntington is a slightly more spread-dependent, balance-sheet-driven franchise than its Ohio twin.

Two segments, plus Treasury/Other. Unlike FITB’s three-segment cut, Huntington reports through two business segments and a Treasury/Other function:

(FACT — FY2025 10-K, segment discussion.) Both segments posted small (2–3%) net-income declines in FY2025 as NIM compression in the falling-rate environment and a rising provision offset volume growth — a reminder the segment economics are rate- and credit-cyclical, not secularly compounding.

The deposit franchise — granular and low-beta, not a high-NIB story. This is the single most important asset, and its texture differs from the FITB twin. At year-end 2025, total deposits were $176,610M: noninterest-bearing demand $32,205M (18%), interest-bearing demand $48,510M (27%), money market $65,123M (37%), savings $15,426M (9%), and time deposits $15,346M (9%). 70% of deposits are insured, only 30% uninsured — a granular, retail-heavy base that proved resilient in the 2023 deposit scare. (FACT — FY2025 10-K.) Note the 18% non-interest-bearing mix is actually lower than FITB’s 24.8% — so Huntington’s funding advantage does not come from an unusually large free-funding layer. It comes from two other places: (1) a best-in-class cumulative total deposit beta of 35% through Q4-2025, so deposit costs fall fast as rates fall, and (2) low single-customer concentration in a consumer-dense base. The average cost of total interest-bearing deposits fell to 2.41% in FY2025 from 2.84% in FY2024. (FACT — 10-K MD&A.) This is the moat question of §4.

Loan book — commercial-tilted, with a genuine consumer-specialty niche and notably low CRE. Total loans and leases were $149,642M at year-end 2025 (≈60% commercial / 40% consumer): C&I $69,442M (46%), CRE only $15,209M (10%), lease financing $5,727M (4%); residential mortgage $24,777M (17%), automobile $16,168M (11%), home equity $10,395M (7%), RV & marine $5,682M (4%), other consumer $2,242M (1%). (FACT — 10-K loan footnote.) Two structural points matter. First, CRE is only ~10% of loans — a deliberately low concentration that de-risks the office/CRE overhang haunting the sector. Second, the auto/dealer-floorplan + RV & marine + powersports indirect-lending complex is a national specialty franchise built on deep dealership relationships, a niche where Huntington has scale and underwriting know-how most super-regionals lack.

Fee income — diversified, payments-led. FY2025 noninterest income of $2,175M breaks down as: payments & cash management $664M (the largest, recurring), wealth & asset management $409M, customer deposit & loan fees $390M, capital markets & advisory $346M, mortgage banking $141M, insurance $81M, leasing $66M, net securities losses ($58M, a repositioning trade), and other $136M. (FACT — 10-K.) No single line dominates, and the two highest-quality annuity streams (payments, wealth) are the two largest — a constructive mix, if smaller in absolute terms than FITB’s payments engine.

Footprint and scale. At year-end 2025, Huntington operated more than 1,000 branches across 14 states, dense in the Midwest (Ohio, Michigan, Illinois, Indiana, Pennsylvania, Minnesota); post-Cadence it operates nearly 1,400 branches across 21 states. Deposit-share leadership is concentrated and real: #1 in Columbus OH (44% share), #1 in Grand Rapids and Akron, #2 in Cleveland, top-five in Detroit, Minneapolis and Indianapolis. (FACT — 10-K, FDIC June-2025 data.)

Recurring vs. cyclical. Roughly three-quarters of revenue is NII — inherently rate- and credit-cyclical, and a price-taking business on both loan yields and deposit pricing. The fee base (payments/treasury management and wealth) supplies the more recurring, annuity-like ballast. Verdict (Business Overview): a diversified, deposit-funded super-regional distinguished by an unusually granular, low-beta, consumer-heavy funding base, a low-CRE/specialty-consumer loan mix, and a peer-leading customer-experience brand — but a fundamentally cyclical, spread-driven core whose headline scale is now acquisition-built. A very good operator inside an ordinary business model — the theme of the whole memo.

3. Industry Dynamics

Structure. U.S. super-regional banking is a fragmented-but-consolidating industry that sits structurally below the average business. The core product — credit extension and deposit-taking — is commoditized; switching costs exist but erode; the industry is intensely and increasingly regulated; and returns are cyclical, geared to the level and shape of the rate curve and to the credit cycle. Profit pools split between net interest margin (a function of rate levels, the curve, funding-cost discipline, and deposit beta) and fee income (payments, wealth, capital markets, card). The four money-center banks (JPMorgan, BofA, Wells Fargo, Citi) enjoy genuine national scale and funding advantages; super-regionals — Huntington, FITB, KeyCorp, Regions, Citizens, M&T, PNC, U.S. Bancorp, Truist — occupy a middle tier; and a long tail of community banks and credit unions competes on local relationships. (INTERPRETATION, grounded in the 10-K competition discussion.)

The scale ceiling. The defining competitive-structure fact for any super-regional is that it sits below the money-centers on the two axes that compound: marginal cost of funds and technology spend. The big four amortize multi-billion-dollar technology budgets over a far larger revenue base and carry a too-big-to-fail funding-perception edge. A super-regional cannot out-invest them on digital, payments, or data at the platform level; it can only (a) win local deposit-share density and relationship depth, and (b) carve defensible niches. Huntington does both unusually well (Midwest density; the auto-dealer/RV-marine specialty; a category-leading digital experience), but the ceiling is structural — even the best-run super-regional earns a step below the scale leaders on the economics that matter most. (INTERPRETATION; Greenwald economies-of-scale lens.) This ceiling is precisely why the consolidation wave exists.

The capital cycle (Marathon lens). Regional banking is mid-way through a consolidation wave — and Huntington is one of its most active participants (TCF 2021 → Veritex 2025 → Cadence 2026), alongside FITB/Comerica, Capital One/Discover, and PNC/FirstBank. Capacity (charters, overlapping branches, excess deposits chasing scant loan demand) is slowly being removed, which is mildly supply-favorable for scaled survivors. But — critically — this consolidation is driven by regulation and scale economics, not pricing discipline. Banks are not exiting because spread returns are unbearable; they are merging to spread compliance and technology costs over a larger base and to reach regulatory tiers efficiently. That distinction matters in the Marathon framework: this is not the kind of supply-rationalizing capital cycle that confers pricing power (as in global beer). Deposit pricing remains competitive; high-yield online savings, money-market funds, and instant digital transfers have, if anything, raised the price-sensitivity of the marginal deposit dollar since 2023. The capital cycle here removes physical capacity but does not confer pricing power. (INTERPRETATION; Marathon capital-cycle.)

A second Marathon flag: this is a phase of heavy bank-M&A at full-to-premium valuations funded with equity — a classic asset-growth signal academic work associates with below-average subsequent returns for the acquirers. HBAN’s own share count tells the story: ~1.02B (2020) → ~1.57B (2025) → ~2.03B post-Cadence. The burden is on Huntington to prove its three deals are the disciplined exception.

The 2023 stress and its legacy. The March-2023 failures of SVB, Signature, and First Republic permanently re-priced two things industry-wide: the perceived stickiness of deposits (deposit betas and uninsured ratios now carry a risk premium), and the market value of AFS/HTM securities portfolios (the AOCI hole). Huntington came through 2023 without a deposit run — its 70%-insured, granular retail base and 35% deposit beta are exactly the profile that proved resilient — and its AOCI drag is now healing.

Regulation — the key structural headwind, now stepping up for HBAN specifically. Huntington was a Category IV organization at year-end 2025; the Cadence close pushes consolidated assets above $250B, moving Huntington and the Bank into Category III by ~Q4-2026 after a transition period. (FACT — 10-K; merger materials.) Category III brings LCR/NSFR liquidity requirements, monthly (vs. quarterly) liquidity stress testing, single-counterparty credit limits, and potential AOCI inclusion in regulatory capital — a permanent step-up in fixed compliance cost and capital sensitivity. Layered on top: the still-pending long-term-debt/“clean holding company” proposal, the unsettled Basel III endgame (which management argues will be net-beneficial to its capital position), CFPB consumer-finance oversight (relevant to the consumer-heavy book), and heightened CRE supervisory scrutiny (less binding given HBAN’s low 10% CRE). Regulation is the single largest structural weight on the industry’s through-cycle returns and is now a larger burden for HBAN than a year ago.

Verdict (Industry Dynamics): a structurally below-average industry. Commodity economics, rate/credit cyclicality, intense and rising deposit competition, and a heavy and increasing regulatory burden cap through-cycle returns even for good operators. The consolidation wave modestly favors scaled survivors but is regulation- and cost-driven, not a pricing-power cycle — so it does not rescue the industry’s structural mediocrity. Only banks with a durable funding-cost advantage and genuine local scale earn excess returns here, which sets up the §4 question.

4. Competitive Position

The question that decides the thesis. A spread lender is worth owning only if it has a structural cost-of-funds advantage or a real source of customer captivity that survives competition. Everything else — underwriting, expense discipline, risk management — is necessary but replicable. So: does Huntington have a moat, and of what type?

Greenwald taxonomy. Huntington’s advantage is best characterized as moderate, region-specific economies of scale (Midwest deposit-share density) combined with above-average demand-side customer captivity — sourced from a category-leading consumer/small-business experience and deep auto-dealer relationships. It is a narrow, local moat — real enough to support through-cycle returns above the cost of equity, but not a wide moat, and partly exposed to the industry-wide erosion of deposit switching costs.

The case FOR an advantage — and crucially, it shows up in the financials:

• Best-in-class deposit beta and low-cost, granular funding. A 35% cumulative total deposit beta in the easing cycle and a 70%-insured, consumer-dense base mean Huntington’s funding cost falls fast when rates fall and stays sticky when they don’t. (FACT — 10-K.) This is the raw material of an above-average spread — and, unlike a pure NIB-mix story, it reflects relationship stickiness and low rate-shopping behavior, the demand-captivity signal Greenwald looks for. The funding edge is genuine, if measured in tens of basis points rather than as a categorical advantage.
• A genuinely differentiated, measured customer-experience moat. This is where HBAN separates from the peer pack. Its “Fair Play” banking suite (24-Hour Grace, Asterisk-Free Checking, $50 Safety Zone, Standby Cash, Early Pay, Money Scout) converts into the captivity metrics that matter: #1 in the J.D. Power 2026 U.S. Online Banking and U.S. Mobile App studies, historically #1 in J.D. Power small-business satisfaction, and peer-leading household growth (+2.0% consumer, +2.1% business in 2025). (FACT — J.D. Power 2026; IR.) In Greenwald terms, demonstrated customer captivity (high satisfaction → low attrition → primary-bank deepening → low deposit beta) is the clearest evidence the moat is more than execution.
• Local scale density. #1 deposit share in Columbus (44%), Grand Rapids and Akron; top-five across Detroit, Cleveland, Minneapolis, Indianapolis. In banking, scale is local, not national — density lowers cost-to-serve and reinforces brand familiarity.
• The auto-dealer / RV-marine specialty. Decades-deep dealership relationships across automobile, RV, marine and powersports indirect lending, plus dealer floorplan and dealer deposits, form a national niche with real switching costs (a dealer does not move its floorplan-and-deposit relationship for a few basis points) and underwriting know-how peers can’t replicate at scale.
• Conservative credit culture — durable and value-protective. NCOs of just 0.23% in FY2025 (vs. FITB’s 0.60%), an NPA ratio of 0.63%, and ~10% CRE concentration evidence a genuine, sustained low-risk appetite. Maintained over decades, credit discipline becomes a real source of through-cycle return advantage and tail-risk protection.

The case AGAINST a wide moat (the more important read):

• Returns are good-but-ordinary, not Greenwald-grade. ROA ~1.05% and ROCE ~10.8% (FY2025) are respectable for a regional but are not the sustained 15–25% after-tax ROIC of a structural franchise. The 16–17% ROTCE is partly a function of financial leverage and an AOCI-reduced tangible-equity denominator, not of unusual business economics.
• Two-thirds-plus of revenue is a price-taker business. On vanilla loans and deposits, Huntington sets price at the market. The funding edge is real but relative and modest.
• The efficiency ratio LAGS the best peers — a genuine blemish. Huntington’s 59.9% efficiency ratio (FY2025) is worse than FITB (~54%) and Regions (~57%). For a bank that wins on customer experience, the cost structure is heavier than the leaders’ — which is precisely why management is pursuing Cadence cost-out to drive Q4-2026 efficiency into the mid-to-low-54% range. The moat has not yet translated into best-in-class operating leverage.
• Switching costs are eroding industry-wide. Digital account opening, rate transparency, and fintech competition lower the friction that historically protected deposit franchises; 2023 showed how fast money can move.

Direct peer framing.

(HBAN: FACT, FY2025 10-K / Q1’26 call. Peers: web-sourced FY2025/Q3–Q4’25 disclosures; directional.)

The read: Huntington is an above-average operator on deposit beta, credit, and customer experience, but a below-average operator on efficiency — Regions out-earns it on ROTCE/ROA partly on a structurally higher-NIM Southeast footprint, and FITB out-operates it on cost. HBAN’s distinguishing features are its low deposit beta + benign credit + best-in-class digital/small-business experience, not unique balance-sheet economics.

Verdict (Competitive Position): a narrow, local moat — a well-run commodity spread bank with an above-peer (not unique) funding-stability advantage, a measurably superior customer-experience/captivity franchise, a genuine auto-dealer specialty, and conservative credit, offset by a lagging efficiency ratio. It passes the Greenwald test narrowly because the captivity is measurable (J.D. Power #1, low beta, household growth) rather than asserted. But the moat is not wide; the efficiency gap shows the operating advantage is incomplete; and the funding edge is relative and modest. If the customer-experience lead or the low deposit beta eroded, the excess return would compress toward the peer mean — the correct test of whether a moat exists, which HBAN passes, but only narrowly.

5. Growth History and Forward Opportunities

Historical growth — real organic household growth, but headline growth is increasingly inorganic. Huntington’s FTE revenue base grew from ~$4.8B (2020) to $8.2B (2025), and net income to common from $717M to $2,087M — but a large share is the cumulative effect of three acquisitions, not organic compounding. Standalone organic revenue is sub-GDP and rate-dependent: FY2025 total revenue (FTE) rose ~11% to $8,231M, but that was boosted by NIM recovery (+13bp to 3.13%), an 8% rise in average earning assets, and the partial-year Veritex contribution. (FACT — 10-K.)

Where the higher-quality organic growth is:

• Primary-bank household growth — the best organic signal. +2.0% consumer and +2.1% business household growth in 2025, credibly peer-leading given the J.D. Power evidence — the engine that, compounded, deepens the low-beta deposit base. Genuine, capital-efficient, franchise-building growth.
• Wealth & asset management (+12% to $409M) and payments & cash management (+7% to $664M) — capital-light, recurring fee streams, the highest-quality growth in the P&L.
• Geographic/vertical expansion: organic de-novo build-out in the Southeast (Carolinas) and the Texas push (now turbocharged by Veritex + Cadence), plus new commercial verticals (healthcare, fund finance, financial sponsors, Native American financial services).

Where the lower-quality / cyclical growth is: the auto/indirect-consumer and RV-marine books grow with consumer credit appetite — thin-spread, credit-cyclical, loss-prone when the cycle turns (though HBAN’s 0.29% consumer NCO shows disciplined underwriting so far). Average commercial loans grew 13% in 2025, but a chunk is acquired.

Inorganic growth — three deals, Texas-anchored:

• TCF Financial (closed June 2021): ~$22B all-stock merger of equals, creating a top-20 bank, adding Michigan/Chicago/Minnesota density. The relevant precedent for integration capability.
• Veritex Holdings (closed Oct 20, 2025): $1.9B all-stock (1.95x ratio), adding ~$13B assets / ~$9B loans / ~$11B deposits in Dallas/Houston — the Texas beachhead.
• Cadence Bank (closed Feb 1, 2026): ~$7.4B all-stock (2.475x ratio), adding $54B assets / $37B loans / $44B deposits across Texas, the Southeast and Mississippi — the transformational deal (~4–5x Veritex) that makes Texas/Southeast a second core franchise and crosses HBAN into Category III.

Marathon’s asset-growth anomaly applies directly. Rapid, equity-funded balance-sheet growth via acquisition is historically associated with below-average subsequent acquirer returns; the burden is on management to prove this trio compounds value rather than diluting it. The favorable precedent (TCF executed without disaster) supports cost-synergy execution capability; the cautionary read is that Veritex and especially Cadence bring large, non-overlapping Texas/Southeast markets with fewer duplicative branches to close, so revenue and talent retention — not just cost-out — become the swing variables. The early-2026 evidence is constructive: Q1-2026 adjusted EPS +9%, PPNR +36%, NIM 3.24% (+9bp q/q), with the 2027 ROTCE target raised to 18–19% and the Q4-2026 efficiency target lowered to mid-to-low-54%. Veritex conversion is complete; Cadence conversion is scheduled for June 2026.

Forward opportunities and their quality:

• High quality: continued primary-bank household growth (the flywheel); Wealth/AUM and payments scaling; the Southeast/Texas footprint as a structurally faster-growing deposit and middle-market market.
• The big swing: extracting the Cadence (and residual Veritex) cost synergies on schedule to drive the efficiency ratio into the low-54s and ROTCE to 18–19% — the single largest determinant of HBAN’s earnings growth over 2026–2028.
• Lower quality / cyclical: auto/indirect-consumer and RV-marine volume.

Verdict (Growth): low-to-moderate quality, with one genuinely high-quality organic core. The peer-leading household growth is real, franchise-building, and capital-efficient — the best part of the story and evidence the moat is working. But the headline growth over 2025–2028 is dominated by the TCF → Veritex → Cadence acquisition stack plus cost-out and Texas expansion — i.e., by M&A and efficiency, not organic demand — which is lower-quality, execution-dependent growth carrying the Marathon asset-growth caveat. This is a mature, well-liked franchise using disciplined M&A and (prospective) cost discipline to manufacture above-organic earnings growth, with the Cadence integration as the proof point that will define the next three years.

6. Financial Quality

Multi-year financial summary

2020–2022 NII/fee/revenue/efficiency/NIM are reconstructed estimates blending the June-2021 TCF close and ROIC totals; FY2023–FY2025 figures are taken directly from the FY2025 10-K three-year comparison. Treat 2020–2022 efficiency/NIM as Interpretation-grade; 2023–2025 as Fact.

Revenue engine and operating leverage (FACT). The top line grew from ~$4.8B (2020) to $8.13B GAAP / $8.23B FTE (2025), but the headline spans the TCF and Veritex closes. The cleaner story is in the margins: FY2025 FTE NII rose 12% to $6,056M on a 13bp NIM recovery to 3.13% and an 8% ($13.9B) rise in average earning assets. Fee income reached $2,175M (+7%), with breadth across payments (+7%), wealth (+12%) and capital markets (+6%). The efficiency ratio improved to 59.9% from 60.5% (2024) and 61.0% (2023), delivering positive operating leverage even while absorbing $168M of Veritex acquisition expense. PPNR momentum is accelerating: Q1-2026 showed adjusted PPNR +36% and NII +33% YoY, with NIM expanding a further 9bp to 3.24%. This is the signature of a bank whose scale benefits actually flow through.

Deposit franchise (FACT/INTERPRETATION). Total deposits were $176.6B at YE2025, ~70% insured, with only $5.9B brokered — a granular, relationship-driven book. In the falling-rate cycle that began Q3-2024, the cumulative total deposit beta was just 35% through Q4-2025, and the cost of total interest-bearing deposits fell to 2.41% from 2.84%. A low down-beta means deposit costs reprice down faster than asset yields — exactly why NIM is expanding off the 2024 trough. This deposit pricing power is the clearest financial expression of the franchise’s moat.

Credit quality (FACT). Credit is top-quartile and conservatively reserved. Net charge-offs were 0.23% of average loans in 2025 (0.30% in 2024), and only 26bp in Q1-2026 — well below peer median. The NPA ratio was 0.63% (flat vs. 2024); total NPAs $945M. The ACL stood at $2,743M, 1.83% of loans — above-peer coverage — though it drifted down from 1.88% in 2024. Direct read: the ACL-to-loans erosion (1.88%→1.83%) modestly flatters the provision line even as the book grew through acquisition; this is coverage normalization, not an outright reserve release, but the FY2025 provision of $463M (+10%) would have been higher had coverage been held flat. On absolute terms the reserve remains genuinely conservative, and CRE office — the single most-watched exposure — carries the largest qualitative risk-profile reserve.

Capital and AOCI (FACT). At YE2025, CET1 was 10.4%, Tier 1 12.0%, total RBC 14.2%, Tier 1 leverage 9.3%. The standout improvement is tangible capital: TCE/TA rose to 7.1% from 6.1%, helped by a ~$960M reversal of the AOCI securities mark (accumulated other comprehensive loss narrowed to $(1,904)M from $(2,866)M as rates fell). This AOCI tailwind is a structural positive for tangible book that should continue if the front end stays anchored; a rate back-up would re-impose the drag — and under Category III, AOCI may flow into regulatory capital, amplifying the sensitivity. Post-Cadence (Q1-2026), CET1 was 10.2% and tangible book per share ~$9.45 (see §10), as the all-stock Cadence deal added ~$3.5B of goodwill and was modestly TBV-dilutive per share.

Quality of earnings (FACT/INTERPRETATION). FY2025 earnings are reasonably clean but carry several normalizing items: $168M Veritex acquisition expense ($129M after-tax, −$0.09 EPS); a $58M net securities loss (vs. $21M in 2024) from corporate-debt repositioning; a $24M trust/custody-sale gain; and a declining FDIC special-assessment drag (deposit-insurance expense −44%). Net-net the one-timers roughly offset; reported $1.39 diluted EPS slightly understates a normalized run-rate (closer to ~$1.48 ex-acquisition cost), which matters for valuation.

Verdict (Financial Quality): economics clearly improve with scale — durable ~16–17% ROTCE, 1.05% ROA, expanding NIM, sub-peer NCOs, above-peer reserves. This is a structurally good bank. The asterisks: the 59.9% efficiency ratio lags the best peers, the ACL has drifted down into a transformation, and — most importantly — the quality has not fully translated into per-share compounding (diluted EPS was higher in 2022 than 2024) because of relentless all-stock dilution and a four-year buyback drought. Good bank; the per-share record needs the next phase to deliver.

7. Capital Allocation

The M&A-driven dilution story (FACT/INTERPRETATION). Huntington’s capital allocation over five years is overwhelmingly an acquisition story, all financed with stock. TCF (closed June 2021) drove share count from 1.017B to 1.438B — a ~41% increase in one move. Veritex (closed Oct 2025): $1.9B all-stock, 1.95x ratio, ~$13B assets. Cadence (closed Feb 1, 2026): ~$7.4B all-stock, 2.475x ratio, creating a ~$276B-asset, ~$220B-deposit top-ten U.S. bank; ex-Cadence CEO Dan Rollins became non-executive Vice Chairman. Plus Janney and TM Capital capital-markets bolt-ons (2025–26, “accretive within three months”). Diluted shares went from 1,033M (2020) to 1,505M (2025) and step to ~2,027M with Cadence.

The blunt assessment: diluted EPS to common rose only from $0.69 (2020) to $1.39 (2025) — and was higher in 2022 ($1.45) than in 2024 ($1.22). The franchise roughly doubled in assets while per-share earnings grew far less; serial all-stock issuance, the AOCI drag, and the absence of buybacks held back per-share value creation. Management’s thesis is that scale + synergies + Texas/Southeast growth justify the dilution, and the rising ROTCE target (16–17% → 18–19% by 2027) is the metric by which to hold them to it. A defensible but unproven bet; integration of Cadence’s Texas/Southeast book is the key execution risk.

Buybacks — the missing bridge (FACT). The record is unambiguous: Huntington repurchased zero shares in 2023, 2024 and 2025. The Board authorized a $1.0B program in April 2025, but no shares were bought under it. Capital was instead retained to fund organic loan growth and absorb the all-stock deals. The pivot is happening now: a new $3.0B “evergreen” repurchase authorization and a guided ~$550M of buybacks in 2026 (and similar in 2027), framed as a return to consistent shareholder returns enabled by strong capital generation and lower-than-expected Cadence dilution. Whether this executes — or is again deferred for the next deal — is the open question; the four-year drought argues for skepticism until shares are actually retired, and the gap between a $3B authorization and a $550M plan tempers the optics.

Dividend (FACT). The common dividend has been flat at $0.62/share declared (2020–2025), yielding ~3.7% at $16.86, well-covered (payout ~45% of EPS) but with negligible growth. The company issued $741M of perpetual preferred (Series K, 6.250%) in September 2025 and assumed Cadence’s preferred as a new Series L — a growing preferred stack whose fixed coupons are a quiet drag on common earnings.

Incentive alignment (FACT) — a genuine positive. The 2026 proxy ties pay to the right metrics. The annual MIP is weighted on Adjusted EPS, Adjusted PPNR Earnings Growth, and Adjusted Operating Leverage (funded at 149% for 2025). Long-term PSUs (60% of CEO LTI) vest on Relative + Absolute Adjusted ROTCE over three years, with the proxy explicitly arguing “higher ROTCE correlates to higher valuations.” Crucially, comp is not tied to asset growth or deal volume — which materially mitigates the empire-building risk serial all-stock acquirers usually carry. CEO Steve Steinour has run the company since January 2009 (~17 years), a long, stable, returns-focused tenure.

Verdict (Capital Allocation): well-incentivized and a disciplined credit underwriter, but the capital-return execution has been poor (no buybacks 2023–25, flat dividend), and the equity’s forward return now hinges almost entirely on whether the Cadence/Veritex stock-funded scale-up earns its dilution. Intelligent-but-unproven on the M&A leg; weak-but-improving on the return leg. The proof points to watch are realized TBV-per-share growth and whether the promised buyback actually retires shares.

8. Changes and Headwinds — Last Two Years

The defining feature of the trailing two years is a deliberate transformation from a ~$190B-asset Midwest super-regional into a top-ten U.S. bank (~$276B assets) via a rapid, all-stock M&A campaign, executed alongside a post-rate-shock margin recovery and a step-change in the bank’s regulatory perimeter.

1. The M&A campaign — three deals in eighteen months, all stock. (FACT.) TCF (merger of equals, June 2021) → Veritex (Dallas, Oct 20, 2025, $1.9B) → the Janney and TM Capital capital-markets bolt-ons → the transformational Cadence Bank (Feb 1, 2026; ~$7.4B all-stock at 2.475x; ~$54B assets / ~$44B deposits). Cadence pushes Huntington into the top-ten U.S. banks and across the $250B threshold into Basel Category III. INTERPRETATION: the strategic logic is coherent and is the most important positive change of the period — Huntington is deliberately building a second core franchise in Texas and the Southeast to escape the slow-growth Midwest map, while building a fee-generating capital-markets engine (a “record capital-markets quarter” in Q1-2026). The bear reading deserves equal weight: this is serial all-stock acquisition into a mediocre, low-organic-growth industry; each deal dilutes tangible book and creates multi-year integration and earnback risk, and the strategy’s quality will be judged by realized TBV-per-share growth and clean integration, neither yet proven.

2. Leadership and board changes. (FACT.) The Cadence 8-K expanded the board from 12 to 15, adding three former Cadence directors (James D. “Dan” Rollins III, Virginia A. Hepner, Alice Rodriguez). Rollins serves as non-executive Vice Chairman and made an open-market purchase of ~22,000 shares in June 2026 — a modest but genuine insider-conviction signal from the acquired-side CEO. Above all, CEO Steve Steinour’s ~17-year tenure is both a strength (he turned a near-death-experience 2009 bank into a consistent ~1% ROA franchise) and a growing key-person/succession concern (§9).

3. Capital actions — resumption of return, and a heavier preferred stack. (FACT.) No buybacks across 2023–2025; then the pivot — a new $3B evergreen authorization plus ~$550M planned for both 2026 and 2027. The common dividend held flat at $0.62. On funding, the bank issued Series K 6.250% preferred (~$741M, Sept 2025) and assumed Cadence’s preferred as Series L. INTERPRETATION: the buyback resumption is a positive signal, but a $3B authorization with only a $550M plan is permission, not commitment, and the four-year drought means management has not yet demonstrated it will return capital at scale rather than redeploy into the next deal.

4. The regulatory step-up to Category III — a permanent cost. (FACT.) Crossing $250B moves Huntington to Category III by ~Q4-2026: LCR/NSFR, monthly internal liquidity stress tests, SCCL, and potential AOCI inclusion in regulatory capital. Management runs adjusted CET1 to a 9–10% operating range and, notably, expects “Basel III Endgame to be beneficial to our regulatory capital position.” INTERPRETATION: Category III is a permanent compliance and capital fixed-cost step-up that structurally lowers the through-cycle ROE ceiling for the $250B+ tier — a genuine headwind — but HBAN’s low CRE, insured deposits, and management’s net-positive Basel read suggest it is manageable rather than thesis-breaking. AOCI inclusion is the item to watch into 2027.

5. The rate-cycle turn — NIM trough to recovery, and the AOCI reversal. (FACT.) NIM rose from 3.13% (FY25) to 3.24% (Q1’26); NII jumped +33% YoY (partly Cadence); PPNR +36% and adjusted EPS +9% in Q1-2026. The same rate decline is reversing the AOCI hole (a tailwind to tangible book), and the FDIC special-assessment drag has rolled off.

Verdict (§8): the changes net-strengthen the near-term earnings thesis but raise execution and dilution risk and lower the structural return ceiling. The transformation gives Huntington a credible second growth leg, a real fee engine, and a margin/AOCI tailwind that the raised 18–19% ROTCE target capitalizes on. But the same changes import the two largest forward risks — serial all-stock M&A/TBV dilution and a permanent Category III cost — making this a strengthened earnings story resting on unproven integration. Net: strengthens the near-term thesis; the durability of the strengthening is the open question.

9. Risk Analysis

Huntington is a diversified, well-capitalized, deposit-funded spread lender with conservative credit metrics — so the probability of catastrophic loss is low. The relevant risks are near-term and idiosyncratic (integration), structural (Category III, serial M&A), and the ordinary cyclical risks of a spread lender, now layered onto a larger, more complex balance sheet.

Catastrophic / total-loss narrative. (INTERPRETATION.) For a well-capitalized, diversified, deposit-funded bank with below-peer CRE, 70% insured deposits, and conservative through-cycle credit, the probability of a permanent total loss is very low. The bank survived its actual near-death experience in 2008–09 and emerged stronger. The only realistic catastrophic path is the classic bank tail: a severe, correlated credit shock (a deep CRE/office or consumer collapse overwhelming the 1.83% reserve) coinciding with a deposit run that forces asset sales into a re-opened AOCI hole — the 2023-style scenario HBAN came through without incident. The enlarged, less-seasoned acquired loan books and concurrent integrations modestly raise this tail versus a year ago, but it remains far out-of-the-money.

Verdict (Risk): real but bounded — dominated by near-term integration execution and a permanent regulatory cost step-up, not by solvency. The probable disappointment is mundane: an integration stumble, slower synergy capture, reserve inadequacy as the acquired books season, or capital redeployed into the next deal rather than returned — any of which would undercut the 18–19% ROTCE target the price increasingly relies on. The asymmetry to respect: the upside (synergies + NIM recovery) is guided and consensus, while the downside (integration + Category III + the next dilutive deal) is structural and underwritten by the strategy itself.

10. Valuation Discussion

The post-Cadence balance sheet — the critical input

The single most important valuation input is the correct post-Cadence book, computed from the Q1-2026 10-Q (period ended March 31, 2026, the first post-deal quarter). Third-party feeds reporting a ~$17.11 book value / ~0.99x P/B are wrong — they sit on a stale share count. The correct figures:

Sensitivity: ex-goodwill-only → P/TBV 1.70x; ex-goodwill-and-all-intangibles → 1.86x. The standard convention (~1.78x) is used as headline. Cadence added ~$3.5B goodwill and new CDI, which is why TBVPS fell from ~$9.89 pre-deal to ~$9.45 — the deal was TBV-dilutive per share even as absolute common equity rose ~$10B.

The multiples, and the central tension

At $16.86, HBAN trades at ~12.1x trailing GAAP EPS ($1.39), ~11.4x normalized EPS (~$1.48), and roughly 10–11x forward 2026E consensus, with 1.15x P/B, ~1.78x P/TBV, and a ~3.7% declared dividend yield. (FACT.)

The apparent tension — “P/E in the 83.6th percentile of its own 10-year history (looks rich) but trades near book (looks cheap)” — is mostly an artifact, and two corrections collapse it:

1. The P/B is not ~1.0x; it is 1.15x, and P/TBV is 1.78x. The third-party “0.99x P/B” sits on a wrong book base. On the correct post-Cadence equity, HBAN trades at a normal ~1.78x premium to tangible book for a 16–17% ROTCE bank — not near tangible book.
2. The 83.6th-percentile trailing P/E is a denominator artifact. Bank P/Es compress in mid-cycle/high-rate windows and expand when EPS is depressed; HBAN’s 2025 EPS carried the Veritex deal charge and half a quarter of Cadence noise, so a 12.1x reading high in its own history reflects a flattish multiple on a temporarily-pressured EPS, not an expensive stock. The §8.5-style caveat applies: for a bank mid-merger, read P/TBV and P/B, not the GAAP P/E percentile. The P/S percentile (47.8th) and composite (65th) read mid-cycle.

So the resolution: HBAN is fairly-to-modestly-cheaply valued — neither the “rich” P/E read nor the “trades at book” cheap read is correct. The honest framing is a 1.78x P/TBV / ~11x forward bank.

Justified P/TBV — the right lens

The Gordon-growth justified multiple P/TBV = (ROTCE − g) / (COE − g) anchors fair value. Inputs: ROTCE ~16–17% (current; 2027 target 18–19%); cost of equity ~10.5% (beta 1.09, ~4.5% risk-free, ~5.5% ERP; a 10–11% band is defensible); long-run growth g ~3.5%.

At the current 16–17% ROTCE and a mid-point COE, justified P/TBV is ~1.85–1.90x — above the current 1.78x. HBAN is therefore modestly cheap to fairly valued on current earnings power, before any synergy or target credit. If the 2027 18–19% target is delivered, justified P/TBV moves to ~2.0–2.2x — a 15–25% re-rating runway on the multiple alone, on top of TBV accretion as Cadence cost-saves and the new buyback shrink the share count.

Embedded expectations — synergies are priced out

Inverting the framework: at 1.78x P/TBV, COE 10.5%, g 3.5%, the market underwrites a sustainable ROTCE of ~16% — essentially the current run-rate with zero credit for the 18–19% target, full Cadence cost synergies, or the operating leverage in the mid-low-54% efficiency target. (INTERPRETATION — the key valuation conclusion.) The market is treating HBAN as a steady ~16% ROTCE compounder and asking to be shown the synergies before paying for them — conservative given management’s execution record, but rational given two large deals closed in the last eight months.

Vs. peers and scenarios

HBAN’s 1.78x P/TBV sits at a discount to FITB, RF and USB despite comparable-or-superior ROTCE and materially better credit (NCO 0.23% vs. peers’ 0.45–0.60%). The discount is “explained” by integration overhang, a sub-peer 10.2% CET1, and lower fee diversification than USB/PNC — but on a justified-multiple basis the discount to FITB looks unearned.

• Bear (~1.3–1.5x TBV / ~$13–14.50): integration slips, NIM rolls over, credit normalizes toward peers, CET1 stays sub-peer; ROTCE drifts to ~13–14%.
• Base (~1.75–1.95x TBV / ~$17.50–19.50): 16–17% ROTCE held, Cadence integrated on plan, buyback resumes, NIM ~3.2%+.
• Bull (~2.1–2.3x TBV / ~$20–21): 2027 18–19% ROTCE hit, mid-low-54% efficiency, full synergies, CET1 rebuilds, buyback compounds TBV/share.

Verdict (Valuation): fairly-to-modestly-cheaply valued — not rich. On the correct post-Cadence book it trades at or slightly below its justified multiple on current ROTCE, and at an apparently unearned discount to higher-multiple, worse-credit peers. The market prices roughly today’s ROTCE and explicitly not the Cadence synergies or the 2027 target, leaving the re-rating optionality on the come. The valuation risk is integration/execution, not a stretched multiple.

11. Variant Perception

Consensus. The sell-side is constructively neutral-to-positive but unexcited: Evercore ISI Outperform, PT ~$20 (raised 6/12/26); Stephens Equal-Weight, PT ~$19 (assumed 6/15/26). Both targets sit ~13–19% above the price and imply ~12x forward — a modest premium, not a contrarian or momentum stance. The consensus story: a well-run, conservatively-underwritten Midwest/now-Southeast super-regional that just stepped up to top-ten via Cadence, with best-in-class deposit costs and credit, but carrying integration risk and a sub-peer CET1 that caps near-term capital return. The market is, in effect, waiting for proof — exactly what the embedded-expectations math shows.

The strongest bull case. HBAN is a proven operator de-rated for deal indigestion it has historically digested well. It runs a 35% deposit beta, 70%-insured deposits, NCO 0.23% (less than half FITB’s), low ~10% CRE, and just posted adj PPNR +36% and NIM 3.24% in the first post-Cadence quarter while raising the 2027 ROTCE target to 18–19%. Deliver even the low end and justified P/TBV re-rates to ~2.0x+ — a 15–25%+ multiple re-rate on top of TBV accretion from the resumed buyback — and the unearned discount to FITB/RF closes.

The strongest bear case. Three large deals in four-and-a-half years is a lot of integration in a short window, and the combination — sub-peer 10.2% CET1, a TBV-dilutive Cadence deal, and a 2027 target that requires synergies — means the stock is one integration stumble or one credit-cycle turn from a de-rate. NIM is at risk if the Fed cuts and asset yields reprice faster than HBAN’s already-low deposit costs can fall further (the deposit-beta advantage is asymmetric — it helps more on the way up than the way down). The dividend has been flat since 2022 with no buybacks 2023–25; the new buyback is small against a CET1 the market wants rebuilt first. If ROTCE slips to 13–14%, fair P/TBV is ~1.5x and the stock is expensive at 1.78x.

The 3–5 assumptions that matter most:

1. Cadence synergy realization & integration — the entire re-rating to 2.0x+ TBV hinges on it. Falsified by: missed cost-save milestones, deposit attrition, or a guide-down on the 2027 ROTCE target.
2. Credit holds (NCO ~0.2–0.3%) — the core differentiator. Falsified by: NCO migrating toward 0.40%+ or accelerating ACL builds, especially in the acquired Southeast books.
3. NIM durability through rate cuts — Falsified by: NIM compressing below ~3.0% as the deposit-beta advantage proves asymmetric on the downside.
4. Capital rebuild / buyback cadence — CET1 back toward 10.5%+ while buying back. Falsified by: CET1 stuck sub-peer, buyback paused, dividend frozen further.
5. COE/multiple regime — Falsified by: a regional-bank risk-premium shock (another SVB-style event) re-widening the whole group’s COE.

Factor-positioning read — is consensus offsides? The tape says this is a recovering, dividend-value regional — not a crowded momentum trade and not a falling knife. FactorsToday (All-Factors model, R² 0.84) loads HBAN most heavily on Financials sector (0.76), Regional Banks (0.48), Value (0.39), and (Base model) DividendYield (1.17) — and negatively on Momentum (−0.15) and Quality (−0.12). That profile — value + dividend-yield + bank-beta, slight negative momentum — is the opposite of a crowded, fully-believed momentum name. Relative strength confirms a recovery, not a melt-up: rs_12m +13 (positive), but rs_6m −1.66 and rs_ytd −0.95 (consolidating), ~11% off the all-time high. The stock is mid-uptrend, digesting the Cadence-close spike, not extended. Risk-adjusted track record: y3 +21.5% annualized (Sharpe 0.68), beta 1.09, alpha slightly negative — you’re paid for risk, not getting free quality; lifetime max drawdown −95% is the GFC scar that marks this as a cyclical financial, not a bond proxy. This argues consensus is mildly offsides on the cautious side — the Equal-Weight/12x-forward stance prices roughly current ROTCE and demands synergy proof, while the negative momentum/quality loadings mean the market has not yet rewarded the Q1-2026 operating-leverage inflection. If synergies land, the re-rate has room precisely because the trade is not crowded.

Verdict (Variant Perception): a quality, low-credit-cost regional priced as a “show-me” story, with the synergy/operating-leverage upside un-priced. Consensus is constructively cautious; the factor tape confirms a recovering value/dividend name, not a crowded momentum trade — so the asymmetry favors patient longs if integration delivers. The bear case is real but is an execution/cycle risk, not a valuation-stretch risk. The variant view: the market’s refusal to pay for Cadence synergies is the opportunity if you believe management’s deposit/credit track record carries into integration — and the trap if three deals in four years finally bites.

12. Fact vs. Interpretation Table

13. Open Questions

1. Exact post-Cadence Cadence synergy run-rate and earnback — what cost-save milestones have been hit by mid-2026, and what is the realized (not guided) tangible-book earnback period?
2. Does the buyback actually execute? After a four-year drought, will the ~$550M 2026 plan retire shares, or be deferred for a fourth deal?
3. Deposit/talent retention in non-overlapping Texas/Southeast markets — is the acquired Cadence/Veritex deposit base sticking, or leaking, under HBAN ownership?
4. NIM path through rate cuts — how asymmetric is the 35% deposit beta on the downside; can NIM hold ≥3.2% if the Fed eases further?
5. Category III capital impact — the precise drag from LCR/NSFR and potential AOCI inclusion into 2027; is management’s “Basel endgame is net-beneficial” claim borne out?
6. ACL adequacy — is the 1.83%→ drift coverage normalization or under-reserving as the acquired books season?
7. Succession — who follows Steinour, and when?
8. Precise 2026E consensus EPS and the MSR carve-out within intangibles (TBVPS ranges $9.08–$9.93 across conventions).

14. What Must Be True

For the bull case to be right (constructive):

• Cadence integration lands cleanly — synergies tracking, deposits/talent retained, conversion (June 2026) without disruption. Falsification test: any of two consecutive quarters showing deposit attrition in the acquired markets, a missed cost-synergy milestone, or a guide-down on the 18–19% 2027 ROTCE target.
• Credit stays top-quartile — NCO holds ~0.2–0.3% and the ACL proves adequate as the acquired books season. Falsification test: NCO migrating toward 0.40%+ or a sharp reserve build over the next 12–18 months.
• Capital returns become real — CET1 rebuilds toward 10.5%+ and the buyback actually retires shares. Falsification test: zero meaningful buyback executed through FY2026, or CET1 stuck below 10.3% with no rebuild path.
• The discount to FITB/RF closes — the market re-rates toward ~1.9–2.2x TBV as the synergy proof arrives. Falsification test: HBAN still trading >15% below FITB’s P/TBV a year after clean integration quarters.

For the bear case to be right (cautious):

• Integration leaks value — revenue/deposit attrition in non-overlapping Texas/Southeast markets erodes the synergy math. Falsification test: combined-company NII and deposit balances tracking ahead of plan through 2026.
• The cycle turns before the deal pays off — a recession/CRE shock raises credit costs across the enlarged, less-seasoned book while NIM compresses. Falsification test: NCO and NIM both holding through a Fed easing cycle.
• Management answers the next lull with a fourth dilutive deal instead of the promised buyback. Falsification test: shares actually retired in 2026–27 and no new large acquisition announced.
• Category III proves a bigger drag than guided. Falsification test: CET1 and through-cycle ROTCE absorbing the regime change without falling below ~15%.

The single cleanest bullish trigger: two clean post-Cadence quarters with synergies tracking, NIM ≥3.2%, CET1 rebuilding, and the buyback executing. The single cleanest bearish trigger: deposit/revenue attrition in the acquired markets or a credit-cost surprise that forces a guide-down on the 2027 ROTCE target.

15. Source Appendix

See the Source Appendix (Appendix B) and Diligence Questionnaire (Appendix A) below. Primary sources: HBAN FY2025 Form 10-K (filed 2026-02-13), Q1-2026 Form 10-Q (filed ~2026-04-30), 2026 DEF 14A (2026-03-12), Cadence/Veritex merger 8-Ks and S-4s, Q1-2026 earnings call transcript (2026-04-23), EDGAR Form 4 corpus, ROIC.ai aggregated financials, AZI valuation-index percentiles and price history, FactorsToday factor model, and public peer disclosures (FITB, RF, USB, PNC, TFC, KEY, CFG).

APPENDIX A — Standard Diligence Questionnaire

Supplemental to the research memo. Answers are grounded in the research log; Fact/Interpretation/Assumption labels applied where it matters. Where a question does not map to a bank, the correct sector analog is given. As-of date: 2026-06-19; price $16.86.

General

What thoughtful questions have other investors asked about this company? The recurring institutional questions: (1) Will Cadence integration realize the guided synergies without deposit/talent attrition in non-overlapping Texas/Southeast markets? (2) Does the four-year buyback drought (2023–25) finally end, or is capital redeployed into a fourth deal? (3) Is the 1.83%-and-falling ACL adequate as acquired books season? (4) How asymmetric is the best-in-class 35% deposit beta on the downside if the Fed eases further — can NIM hold ≥3.2%? (5) What is the through-cycle ROTCE ceiling after the Category III cost step-up? (6) Succession for a ~17-year CEO. (INTERPRETATION, from sell-side notes and transcript Q&A.)

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Mid-cycle, inflecting up. NIM troughed at 3.00% (FY2024) and is recovering (3.13% FY2025 → 3.24% Q1-2026) as deposit costs fall; PPNR is accelerating (+36% adj in Q1-2026). Earnings are not at a cyclical high — they are recovering off a rate-compression trough, with a near-term tailwind from the AOCI reversal and Cadence accretion. (FACT/INTERPRETATION.)

Driven by external environment or internal actions? Both. External: the rate-cut path lifts NIM and reverses the AOCI drag. Internal: the Cadence/Veritex scale-up and the targeted cost-synergy program (efficiency toward mid-low-54%, ROTCE toward 18–19% by 2027).

How stable are revenues? Moderately. ~74% of revenue is rate/credit-cyclical NII; ~26% is fee income, of which the two largest lines (payments $664M, wealth $409M) are recurring/annuity-like. More stable than a pure spread lender, less stable than a fee-heavy peer.

Outlook for products/services / market size? The U.S. deposit/loan market is mature and GDP-paced; HBAN’s incremental growth comes from share gains in the Midwest (household growth), the faster-growing Texas/Southeast footprint (Veritex/Cadence), and fee buildout (capital markets, payments, wealth). Large, growing modestly, domestic-only. (INTERPRETATION.)

Business Quality & Competitive Moat

Is the industry getting more or less competitive? More competitive on deposit pricing (online savings, money funds, fintech) since 2023; consolidating on the supply side (fewer charters) but without conferring pricing power (Marathon: capacity removed, no pricing power). Net: structurally intense.

How profitable is the business (ROIC/ROE)? ROA ~1.05%, ROTCE 15.7% GAAP (16–17% adjusted) — good for a regional and above the ~10.5% cost of equity, but not Greenwald-grade. Note: third-party ROE feeds showing ~36% are mis-mapped (wrong equity base); the correct ROTCE is 16–17%. (FACT, with data caveat.)

How profitable is the industry / barriers to entry? Structurally below-average; barriers are regulatory (charters, capital) and local-scale/relationship-based rather than economic. Many competitors (money-centers, super-regionals, community banks, credit unions, fintechs).

Can the business be easily understood? Yes — a deposit-funded spread lender with a fee overlay. The complexity is in the credit book, the securities/AOCI marks, and the purchase accounting from three deals.

Undermined by foreign low-cost labor? No — domestic, regulated, relationship-and-branch-based. Technology/fintech disruption is the more relevant threat.

Do brands matter? Yes, unusually so here. The “Fair Play”/Huntington brand converts into measurable captivity (#1 J.D. Power 2026 consumer digital experience; #1 small-business; peer-leading household growth) — the clearest evidence of the moat.

Nature of competition / switching costs? Competition is on rate, convenience, and relationship. Switching costs are real but eroding (digital account opening, rate transparency). HBAN’s low 35% deposit beta is evidence its customers rate-shop less than peers’ — genuine, if modest, captivity.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The deposit franchise’s intangible value (low-cost, sticky funding) is under-recognized; conversely, ~$9.5B of goodwill (post-Cadence) and CDI are on the books and depress tangible book. MSRs (~$0.7–0.8B) carried within intangibles.

Off-balance-sheet liabilities? Standard for a bank: unfunded loan commitments, standby letters of credit, and derivative/hedging positions — all disclosed in the 10-K. No unusual SPE/VIE exposure flagged.

How conservative is the accounting? Above-average on credit (ACL 1.83%, above-peer) — though the 1.88%→1.83% drift bears watching. Earnings carry normal merger/repositioning one-timers ($168M Veritex deal cost, $58M securities loss in 2025) that roughly offset. (FACT/INTERPRETATION.)

How CapEx-hungry? Bank analog: capital is consumed by RWA/loan growth and acquisitions, not physical CapEx. The relevant metric is CET1 generation vs. consumption — HBAN generates ~10% ROTCE of capital but consumed it on three all-stock deals and minimal buybacks.

Capital Allocation & Management

How much FCF / capital does it generate and how is it used? Bank analog: ~$2.1B net income to common (2025); historically retained to fund loan growth and absorb all-stock M&A, with a flat $0.62 dividend (~45% payout) and zero buybacks 2023–25. The pivot: $3B evergreen authorization + ~$550M 2026 buyback plan. (FACT.)

Significant acquisitions recently? Yes — the central story: TCF (2021, ~$22B), Veritex (Oct 2025, $1.9B), Cadence (Feb 2026, ~$7.4B), plus Janney/TM Capital bolt-ons. All all-stock; share count ~1.02B (2020) → ~2.03B (post-Cadence).

Buying back shares? Not for three years (2023–25). Now authorized ($3B) and planned (~$550M 2026) — permission, not yet proof.

Issuing shares to insiders? Normal SBC via RSU/PSU grants; no abnormal insider issuance. Serial acquisition share issuance is the dilution driver, not insider grants.

Compensation / incentive alignment? Strong. Annual MIP on adjusted EPS, PPNR growth, and operating leverage; long-term PSUs (60% of CEO LTI) on relative + absolute adjusted ROTCE — not asset growth. Mitigates empire-building risk. (FACT.)

Motivations of management? CEO Steinour (since Jan 2009, ~17 yrs) is returns-focused with a long track record; the comp design aligns to ROTCE/EPS. Vice Chairman Rollins (ex-Cadence CEO) made an open-market buy (~22k shares, June 2026) — a mild conviction signal.

Valuation & Market Data

ADR / MLP / K-1? No — a U.S. C-corp common stock on NASDAQ; standard 1099 dividend treatment.

Dividend policy? Flat $0.62/share declared since 2020; ~3.7% yield at $16.86; ~45% payout; well-covered but no growth. Series H/I/J/K/L preferred outstanding.

How profitable? ROA 1.05%, ROTCE 16–17% — see above.

Net income vs. cash from operations diverging? Not materially for a bank; the more relevant divergences are (a) reported EPS vs. normalized (~$1.39 vs. ~$1.48 ex-deal-charge), and (b) tangible-book growth lagging net income because of all-stock M&A goodwill.

Risks & Downside

What would cause the stock to decline? Integration stumble (Cadence/Veritex), credit normalization beyond the 1.83% reserve, NIM compression on a faster-than-expected easing cycle, a sub-peer CET1 forcing the buyback to stay paused, a regional-bank risk-premium shock, or a fourth dilutive deal. (INTERPRETATION.)

Risk of catastrophic loss? Low. Diversified, well-capitalized (CET1 10.2%), low CRE (~10%), 70% insured deposits. The tail path is a severe correlated credit shock + deposit run (2023-style), which HBAN survived without incident.

Chance of a total loss? Very low — would require a systemic event or a massive undisclosed credit hole. Not a base case for a $276B-asset regulated bank.

Recent News & Events

Has the business environment changed recently? Materially, by HBAN’s own design: the Cadence close (Feb 2026) transformed scale, geography, and regulatory category (into Category III). External tailwinds (rates turning down, AOCI reversing, FDIC special assessment rolled off) are constructive.

Significant acquisitions / accounting changes / new markets? Cadence + Veritex (Texas/Southeast as a second core franchise); capital-markets buildout (Janney/TM Capital); new commercial verticals (healthcare, fund finance, financial sponsors). Purchase accounting from the deals is the main accounting change. Board expanded 12→15 with three ex-Cadence directors. Quiet news tape otherwise — recent items are two sell-side notes (Evercore Outperform $20, Stephens Equal-Weight $19) against a $16.86 price.

APPENDIX B — Source Appendix

Primary sources first. All figures in the memo reconcile to these. As-of date 2026-06-19; price reference $16.86 (close 2026-06-18).

Primary — SEC filings (EDGAR, CIK 0000049196)

Primary — Earnings call

Secondary — aggregated data & market